| Literature DB >> 25392670 |
Ioannis D Gkegkes1, Sarantis Mourtarakos2, Christos Iavazzo3.
Abstract
BACKGROUND AND OBJECTIVES: The single-incision approach in laparoscopic surgery is a relatively new concept. This systematic review of the literature was performed to appraise the existing clinical evidence concerning the use of the single-incision technique for spleen resection.Entities:
Keywords: Laparoendoscopic single site; Single incision; Splenectomy
Mesh:
Year: 2014 PMID: 25392670 PMCID: PMC4208906 DOI: 10.4293/JSLS.2014.00350
Source DB: PubMed Journal: JSLS ISSN: 1086-8089 Impact factor: 2.172
Characteristics and Outcomes of Patients After SILS
| Data | |
|---|---|
| Demographic data | |
| Age [median (range)] (y) | 23 (0.6–73) |
| Male sex | 35 of 81 (43.2) |
| Medical history | |
| Presence of comorbidities | 57 of 81 (70.4) |
| BMI [median (range)] (kg/m2) | 23 (18–35.7) |
| Clinical features of SILH performed | |
| Diagnosis | |
| Splenomegaly | 33 of 74 (44.6) |
| Idiopathic thrombocytopenic purpura | 23 of 74 (31) |
| Immune thrombocytopenic purpura | 5 of 74 (6.8) |
| Lymphomas | 5 of 74 (6.8) |
| Splenic cysts | 4 of 74 (5.4) |
| Traumatic rupture | 2 of 74 (2.8) |
| Hydatid cyst | 1 of 74 (1.3) |
| Multiple splenic abscesses | 1 of 74 (1.3) |
| Type of splenectomy | |
| Partial splenectomy | 2 of 81 (2.5) |
| Patient position | |
| Semilateral | 49 of 79 (62) |
| Lateral | 30 of 79 (38) |
| Surgical approach | |
| Umbilical | 57 of 81 (70.4) |
| Periumbilical | 17 of 81 (21) |
| Supraumbilical | 5 of 81 (6.1) |
| Left upper quadrant | 2 of 81 (2.5) |
| Weight of spleen [median (range)] (g) | 446 (125–590) |
| Operative parameters | |
| Port system applied | |
| 2 or 3 single ports (5- to 12-mm trocars) | 43 of 79 (54.4) |
| SILS port | 21 of 79 (26.6) |
| TriPort | 6 of 79 (7.6) |
| Glove port | 5 of 79 (6.3) |
| GelPort | 4 of 79 (5.1) |
| Size of incision [median (range)] (mm) | 22 (10–35) |
| Outcomes | |
| Operative time [median (range)] (min) | 125 (45–420) |
| Blood loss [median (range)] (mL) | 50 (10–450) |
| Conversions | 4 of 81 (4.9) |
| Transfusion needed | 11 of 81 (13.6) |
| Hospital stay [median (range)] (d) | 3 (1–9) |
| Complications | 6 of 81 (7.4) |
| Death | 0 of 81 |
| Positive cosmesis | 42 of 81 (51.8) |
Data are presented as number (percent) unless otherwise indicated.
Main Characteristics and Outcomes of Patients After SILS in Published Case Series
| Author, Year, Country | Publication Type | No. of Patients | Age of Patients (y) | BMI (kg/m2) | Diagnosis | Port System Applied in SILS[ | Weight of Spleen (g) | Size of Incision in SILS (mm) | Duration of Procedure (min) | Blood Loss (mL) | Conversions (%) | Transfusion Needed | Hospital Stay (d) | Complications | Cosmesis |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Boone et al,[ | Retrospective, comparative study | LS[ | LS: 49.3 ± 16.6 (mean ± SD), SILS: 51.4 ± 21.6 (mean ± SD), | LS: 26.9 ± 5.5 (mean ± SD), SILS: 27 ± 8.1 (mean ± SD), | LS: myeloproliferative disorder in 8 of 26 (30.7%), ITP[ | GelPOINT | LS: 473.8 ± 331.8 (mean ± SD), SILS: 422.9 ± 443.6 (mean ± SD), | 40 | LS: 185.9 ± 76.6 (mean ± SD), SILS: 101.6 ± 31.2 (mean ± SD), | LS: 398.1 ± 494.3 (mean ± SD), SILS: 78.9 ± 68.2 (mean ± SD), | LS: 5 of 26 (19.2%), SILS: 0 of 26 | LS: 6 of 26 (23%), SILS: 2 of 26 (7.7%) | LS: 5.1 ± 2.5 (mean ± SD), SILS: 4.4 ± 2.8 (mean ± SD), | LS: 5 of 26 (19.2%), SILS: 2 of 26 (7.7%) | NR[ |
| Choi et al,[ | Retrospective, comparative study | LS: 18 of 34 (53%), SILS: 16 of 34 (47%) | LS: 45.8 ± 20.2 (mean ± SD), SILS: 51.7 ± 12.7 (mean ± SD), | LS: 22.93 ± 2.59 (mean ± SD), SILS: 25.02 ± 4.17 (mean ± SD), | LS: ITP in 11 of 34 (32.3%)[ | OCTO port/glove port | LS: 132.29 ± 72.84 (mean ± SD), SILS: 80.27 ± 38.49 (mean ± SD), | 30 | LS: 88.94 ± 21.68 (mean ± SD), SILS: 95.06 ± 32.35 (mean ± SD), | LS: 206.25 ± 142.45 (mean ± SD), SILS: 111.11 ± 99.58 (mean ± SD), | LS: 0 of 34, SILS: 0 of 34 | LS: 1 of 34 (3%), SILS: 1 of 34 (3%) | LS: 4.67 ± 2.72 (mean ± SD), SILS: 5.13 ± 1.67 (mean ± SD), | LS: 2 of 34 (5.9%), SILS: 1 of 34 (3%) | NR |
| Perger et al,[ | Prospective, comparative study | LS: 14 of 30 (47%), SILS: 16 of 30 (53%) | LS: 7 (2–17) [median (range)], SILS: 7 (1–15) [median (range)], | NR | LS: spherocytosis in 6 of 30 (20%), sickle cell disease in 5 of 30 (17%), ITP in 3 of 30 (10%); SILS: spherocytosis in 8 of 30 (27%), sickle cell disease in 4 of 30 (13%), ITP in 3 of 30 (10%), autoimmune hemolytic anemia in 1 of 30 (3%) | QuadPort | LS: 229 (62–1145) [median (range)], SILS: 169 (49–536) [median (range)], | 15 | LS: 99 (51–154) [median (range)], SILS: 84 (40–190) [median (range)], | LS: 10 (5–60) [median (range)], SILS: 10 (5–600) [median (range)], | LS: 1 of 30 (3%), SILS: 2 of 30 (6%) | NR | LS: 2 (1–5) [median (range)], SILS: 2 (1–8) [median (range)], | LS: 2 of 30 (6%), SILS: 3 of 30 (7%) | NR |
| Monclova et al,[ | Prospective, comparative study | LS: 14 of 32 (43.8%), SILS: 8 of 32 (25%), RPAS[ | LS: 55 ± 18 (mean ± SD), SILS: 50 ± 19 (mean ± SD), RPAS: 41 ± 13 (mean ± SD), | LS: 28 ± 5 (mean ± SD), SILS: 25 ± 4 (mean ± SD), RPAS: 24 ± 4.5 (mean ± SD), | LS: ITP in 13 of 14 (93%), autoimmune hemolytic anemia in 1 of 14 (7%); SILS: ITP in 3 of 8 (37.5%), spherocytosis in 2 of 8 (25%), malignancy in 3 of 8 (37.5%); RPAS: ITP in 8 of 10 (80%), autoimmune hemolytic anemia in 1 of 10 (10%), malignancy in 1 of 10 (10%) | 3 ports/multi-access single port | LS: 212 ± 127 (mean ± SD), SILS: 394 ± 153 (mean ± SD), RPAS: 230 ± 87 (mean ± SD), | NR | LS: 83 ± 19 (mean ± SD), SILS: 131 ± 43 (mean ± SD), RPAS: 81 ± 22 (mean ± SD), | NR | LS: 0 of 14, SILS: 0 of 8, RPAS: 0 of 10 | LS: 1 of 14 (7%), SILS: 1 of 8 (12.5%), RPAS: 0 of 10, | LS: 5 ± 3 (mean ± SD), SILS: 4 ± 2 (mean ± SD), RPAS: 3 ± 2 (mean ± SD), | NR | Body Image Index[ |
| Misawa et al,[ | Prospective study | 10 | 53 (24–66) [median (range)] | NR | ITP in 3 of 10 (30%), liver cirrhosis in 2 of 10 (20%), splenic aneurysm in 2 of 10 (20%), splenic simple cyst in 1 of 10 (10%), epithelial cyst in 1 of 10 (10%), splenic tumor in 1 of 10 (10%) | SILS port | 260 (100–580) [median (range)] | 20 | 230 (150–378) [median (range)] | 15 (0–100) [median (range)] | 1 of 10 (10%) | NR | 6.8 ± 2.3 (mean ± SD) | 0 of 10 | NR |
ITP = immune thrombocytopenic purpura; LS = laparoscopic splenectomy; NR = not referred; NS = not statistically significant; RPAS = reduced–port access splenectomy; SILS = single–port access splenectomy.
The remaining 13 patients had the following diagnoses: autoimmune hemolytic anemia, angiosarcoma, simple cyst, pseudocyst, diffuse large B-cell lymphoma, hemangioma, histiocytic sarcoma, inflammatory pseudotumor, metastatic lung adenocarcinoma, metastatic clear-cell ovarian carcinoma, sclerosing angiomatoid nodular transformation, lymphoid follicular hyperplasia associated with systemic lupus erythematosus, and vascular malformation.
The Body Image Index ranges from 4 (lowest) to 20 (highest).